tirzepatide injection site redness Reactions Injection site reaction -anyone else?

While both agents struggled with the inherent GI burden typical of GLP-1RAs, efpeglenatides limitations were largely dose-related and within manageable expectations, whereas taspoglutides combination of severe immunogenicity and hypersensitivity reactions rendered it clinically unviable

What works wonders for one person might not do much for another

Here is how to prioritize each one

SEMAGLUTIDE HEART RISKS: INCREASED HEART RATE AND HEART FAILURE Semaglutide, like all GLP-1RAs, increases heart rate, as reported in research studies

812 kPa is indeterminate) Consideration of liver biopsy for definitive staging Evaluation for hepatocellular carcinoma screening in cirrhotic patients (ultrasound with or without AFP every 6 months) Patients should be counseled that improvement in liver health is gradual, typically requiring 612 months of consistent treatment and lifestyle modification